Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning

Documenti analoghi

• The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
  di: Bristow, Linda J., et al.
  Pubblicazione: (2016)
• No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model
  di: Baakman, Anne Catrien, et al.
  Pubblicazione: (2019)
• No synergistic effect of subtherapeutic doses of donepezil and EVP‐6124 in healthy elderly subjects in a scopolamine challenge model
  di: Anne Catrien Baakman, et al.
  Pubblicazione: (2019-01-01)
• BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia
  di: King, Dalton, et al.
  Pubblicazione: (2017)
• Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains
  di: Weed, Michael R, et al.
  Pubblicazione: (2016)